Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
earnings-surprise: Archive
Electrovaya Inc. (ELVA) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Electrovaya Inc. (ELVA) delivered earnings and revenue surprises of -166.67% and 34.87%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ELVANegative Net Change GTECNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Home Depot (HD) Q1 Earnings Top Estimates
by Zacks Equity Research
Home Depot (HD) delivered earnings and revenue surprises of 0.55% and 0.64%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?
HDPositive Net Change LOWNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Compared to Estimates, Alcon (ALC) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Alcon (ALC) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ALCNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
StoneCo Ltd. (STNE) Q1 Earnings Surpass Estimates
by Zacks Equity Research
StoneCo (STNE) delivered earnings and revenue surprises of 3.57% and 1.62%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
STNENegative Net Change NCNOPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Orchestra BioMed Holdings, Inc. (OBIO) delivered earnings and revenue surprises of 5% and 51.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
OBIOPositive Net Change ALVONo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Smart Sand (SND) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Smart Sand (SND) delivered earnings and revenue surprises of -120% and 10.44%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
SNDPositive Net Change ISUNNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
FlexShopper Inc. (FPAY) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
FlexShopper (FPAY) delivered earnings and revenue surprises of 40% and 15.85%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
FPAYNegative Net Change XPNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Akoya Biosciences (AKYA) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Akoya (AKYA) delivered earnings and revenue surprises of -16.67% and 23.94%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
AKYANegative Net Change PSTXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
QuickLogic (QUIK) Q1 Earnings Top Estimates
by Zacks Equity Research
QuickLogic (QUIK) delivered earnings and revenue surprises of 83.33% and 3.11%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
QUIKNegative Net Change AVGONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Duos Technologies Group, Inc. (DUOT) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Duos Technologies Group, Inc. (DUOT) delivered earnings and revenue surprises of 11.63% and 14.32%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
DUOTNegative Net Change RAMPNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Hyzon Motors Inc. (HYZN) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Hyzon Motors (HYZN) delivered earnings and revenue surprises of 17.65% and 1,896.60%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
HYZNNegative Net Change BEEMNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Paysafe Limited (PSFE) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Paysafe Limited (PSFE) delivered earnings and revenue surprises of 67.65% and 2.49%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
PSFEPositive Net Change PAGSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Durect (DRRX) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Durect (DRRX) delivered earnings and revenue surprises of -19.05% and 33.08%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
DRRXNegative Net Change OPTNNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Hyperfine (HYPR) delivered earnings and revenue surprises of 0% and 8.75%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
HYPRPositive Net Change ASXCNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Theravance Bio (TBPH) delivered earnings and revenue surprises of 52.63% and 0.25%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
TBPHNegative Net Change MDWDNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Capricor Therapeutics (CAPR) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Capricor (CAPR) delivered earnings and revenue surprises of -181.82% and 50.93%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
CAPRPositive Net Change HITINegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Peraso (PRSO) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Peraso (PRSO) delivered earnings and revenue surprises of 34.13% and 8.31%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
PRSONegative Net Change YEXTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Generation Bio (GBIO) delivered earnings and revenue surprises of -211.11% and 34.63%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
GBIONegative Net Change TSHANegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Agilysys (AGYS) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Agilysys (AGYS) delivered earnings and revenue surprises of 33.33% and 0.62%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
AGYSPositive Net Change ITIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Spruce Biosciences (SPRB) delivered earnings and revenue surprises of 12.50% and 79.55%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
SPRBNegative Net Change STRONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Cara (CARA) delivered earnings and revenue surprises of -47.37% and 5.11%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
CARANegative Net Change AQBNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Allogene Therapeutics (ALLO) delivered earnings and revenue surprises of 0% and 47.62%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ALLONegative Net Change PGENNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Voyager Therapeutics (VYGR) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of 54.55% and 88.87%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
VYGRNegative Net Change BFRINegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Bitdeer Technologies Group (BTDR) Q1 Earnings Meet Estimates
by Zacks Equity Research
BITDEER TEC GRP (BTDR) delivered earnings and revenue surprises of 0% and 0.32%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
BTDRNegative Net Change MRVLNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sterling Infrastructure, Inc. (STRL) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Sterling Infrastructure (STRL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
STRLNegative Net Change MPTINegative Net Change
earnings-surprise price-change style-scores valuation